US Supplement Firm Warned About Phenibut After Failing To Pull PTSD, Detox, Anxiety Claims
Salt Scrubs Join FDA’s List Of Fraudulent COVID-19 Treatment Claims
Executive Summary
Latest FDA warning to Chill6 doesn’t reference previous letter but lists larger number of violations along with more details about the problems. Agency also recently added salt scrub therapies to its list of products as marketed with fraudulent coronavirus treatment claims.
You may also be interested in...
US Enforcement On COVID-19 Consumer Health Fraud Circles Back To Ayurvedic Products
Georgia firm promoted a product as interrupting “infection chain” of coronavirus. Total of fraudulent COVID-19 claims FDA’s found in consumer health space approaches 200.
FDA Debuts List For Rapidly Announcing Noncompliant Ingredients In Supplements
FDA announces addition of Dietary Supplement Ingredient Advisory List page to its website to identify ingredients it has preliminary determined should be used in dietary supplements. It also publishes warning letters submitted recently to firms marketing supplements containing two ingredients agency has concluded should not be used: eight were warned about using an ingredient identified as "DMHA" and three about using phenibut.
Industry Groups Take Lead In Outing Drug Disguised As Dietary Supplement
Four groups say drug identified as “phenibut” is being used in products fraudulently labeled as supplements. The drug, reportedly developed in the former Soviet Union for brain-enhancing properties, has been found in products typically marketed for cognitive benefit and mood enhancement."We're not going to wait for someone to tell us this is not a dietary ingredient," says CRN executive Duffy MacKay.